Read the latest reports on Western Europe, with local insight, sp...
Read the latest reports on Western Europe, with local insight, specialist knowledge and a comprehensive breakdown of key market data. Our research identifies key strategic themes relevant across the region, while also providing a more granular unders...
Rx/reimbursement adult incontinence in France continued its positive growth trend in 2023, in terms of both volume and current value sales, benefitting from the essential nature of the category’s products. There was a small deceleration in the first…
In 2023, rx/reimbursement adult incontinence in Germany continued to record positive value growth, particularly given the increased costs of products and the impact of a high inflation rate. Nevertheless, volume growth decreased marginally, in a…
Rx/reimbursement adult incontinence remained in a slump in Italy in 2023, as the government continues to reduce its spending in the healthcare system. In 2024, public expenditure in hospitals and so-called “Community Health Houses” will be further…
Unit price points for Rx/reimbursement adult incontinence experienced a high but moderating spike in Norway in 2023. This increase can be attributed to inflationary pressures, including rising input costs such as energy, materials, labour, and…
For nearly 40 years. the Spanish Public Health system has included adult incontinence protection in the list of Rx/reimbursement medical products. These products can be purchased through e-commerce and in health and beauty specialists with the…